Naperville, IL -- (SBWIRE) -- 04/13/2015 -- Reportstack, provider of premium market research reports announces the addition of EUROPEAN MARKETS FOR SOFT TISSUE REINFORCEMENT AND REGENERATION market report to its offering

The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a whole. Due to the strictly evidence-based approach throughout Europe, the benefits of biologic products, such as expedited healing and reduced likelihoods of graft rejection, are not seen to outweigh their high costs.

Scope
2011-2021

Companies Mentioned

Covidien
Ethicon
C.R. Bard
Integra LifeSciences
LifeCell
Aesculap/B.Braun
Systagenix
Medskin Solutions
Cook Medical
American Medical Systems
Boston Scientific
Depuy Synthes
Tutogen
Lowmann & Rauscher
Smith & Nephew
Coloplast
PFM Medical
Tornier
Botiss
Geistlich
Baxter/Synovis
Stryker
Serag-Wiessner
Novus Scientific

Complete report is available
http://www.reportstack.com/product/198493/european-markets-for-soft-tissue-reinforcement-and-regeneration.html

Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604